Christopher Brooke

Christopher Brooke

Director de Operaciones en SwanBio Therapeutics, Inc. .

Fortuna: 165 734 $ al 30/04/2024

Health Technology
Consumer Services

Perfil

Christopher Brooke is the founder of Rumpus Therapeutics.
He is currently the Chief Operating Officer at SwanBio Therapeutics, Inc. where he started in 2023.
Prior to this, he was the Chief Operating Officer at Aytu Biopharma, Inc. from 2021 to 2023.
Mr. Brooke received his undergraduate degree from Colgate University and his MBA from The Wharton School of the University of Pennsylvania.

Participaciones conocidas en empresas públicas

EmpresaFechaNúmero de accionesValoraciónFecha de valoración
11/08/2023 58 357 ( 1.05% ) 165 734 $ 30/04/2024

Cargos activos de Christopher Brooke

EmpresasCargoInicio
Director de Operaciones 16/10/2023
Todos los cargos activos de Christopher Brooke

Antiguos cargos conocidos de Christopher Brooke.

EmpresasCargoFin
AYTU BIOPHARMA, INC. Director de Operaciones 13/10/2023
Rumpus Therapeutics Fundador -
Ver el detalle de la experiencia de Christopher Brooke.

Formación de Christopher Brooke.

Colgate University Undergraduate Degree
The Wharton School of the University of Pennsylvania Masters Business Admin

Experiencias
Funciones ocupadas

Activas

Inactivas

Empresas cotizadas

Empresas privadas

Ver el detalle de la experiencia de Christopher Brooke.

Relaciones

20

Relaciones de 1er grado

5

Empresas vinculadas al 1er grado

Hombre

Mujer

Administradores

Ejecutivos

Consultar la red personal

Empresas relacionadas

Empresas cotizadas1
AYTU BIOPHARMA, INC.

Health Technology

Empresas privadas2
Rumpus Therapeutics

Health Technology

Ver las conexiones de la empresa
  1. Bolsa de valores
  2. Insiders
  3. Christopher Brooke